ADCT
Price
$3.62
Change
+$0.07 (+1.97%)
Updated
Jan 16 closing price
Capitalization
448.44M
53 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$3.55
Change
+$0.67 (+23.26%)
Updated
Jan 16 closing price
Capitalization
197.67M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs QNCX

Header iconADCT vs QNCX Comparison
Open Charts ADCT vs QNCXBanner chart's image
ADC Therapeutics SA
Price$3.62
Change+$0.07 (+1.97%)
Volume$754.25K
Capitalization448.44M
Quince Therapeutics
Price$3.55
Change+$0.67 (+23.26%)
Volume$2.86M
Capitalization197.67M
ADCT vs QNCX Comparison Chart in %
ADCT
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADCT vs. QNCX commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (ADCT: $3.62 vs. QNCX: $3.55)
Brand notoriety: ADCT and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 59% vs. QNCX: 298%
Market capitalization -- ADCT: $448.44M vs. QNCX: $197.67M
ADCT [@Biotechnology] is valued at $448.44M. QNCX’s [@Biotechnology] market capitalization is $197.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 4 bearish.
  • QNCX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than QNCX.

Price Growth

ADCT (@Biotechnology) experienced а -1.09% price change this week, while QNCX (@Biotechnology) price change was +31.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($448M) has a higher market cap than QNCX($198M). QNCX YTD gains are higher at: 5.970 vs. ADCT (2.550). QNCX has higher annual earnings (EBITDA): -44.18M vs. ADCT (-112.75M). ADCT has more cash in the bank: 235M vs. QNCX (26.3M). QNCX has less debt than ADCT: QNCX (18M) vs ADCT (117M). ADCT has higher revenues than QNCX: ADCT (75.2M) vs QNCX (0).
ADCTQNCXADCT / QNCX
Capitalization448M198M226%
EBITDA-112.75M-44.18M255%
Gain YTD2.5505.97043%
P/E RatioN/AN/A-
Revenue75.2M0-
Total Cash235M26.3M894%
Total Debt117M18M650%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTQNCX
RSI
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANICF0.200.01
+2.95%
ANONYMOUS INTELLIGENCE CO INC.
JBTC34.30N/A
N/A
JBT Bancorp Inc.
AUHYF1.42N/A
N/A
Anadolu Hayat Sigort As
FANDY55.94N/A
N/A
Firstrand Limited
RTMVY13.77-0.01
-0.07%
Rightmove Plc

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+1.97%
CLRB - ADCT
41%
Loosely correlated
-1.64%
QTTB - ADCT
41%
Loosely correlated
N/A
RGNX - ADCT
38%
Loosely correlated
-1.02%
ANAB - ADCT
36%
Loosely correlated
-1.36%
IMTX - ADCT
36%
Loosely correlated
-0.91%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+23.26%
MNPR - QNCX
35%
Loosely correlated
+1.35%
RAPT - QNCX
34%
Loosely correlated
+9.04%
ADCT - QNCX
31%
Poorly correlated
+1.97%
SGMO - QNCX
30%
Poorly correlated
-6.65%
CLNN - QNCX
29%
Poorly correlated
-1.17%
More